Abstract
16129 Background: Gemcitabine (G) has emerged recently as a safe and potentially active treatment for superficial bladder cancer. Gemcitabine is also considered a very potent radiosensitizing agent...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have